SC
IMA

Shay Capital’s ImageneBio Inc IMA Stock Holding History

Shay Capital’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Sell
18,080
-1,050
-5% -$5.93K 0.01% 442
2026
Q1 		$95.7K Sell
19,130
-4,086
-18% -$26.5K 0.01% 438
2025
Q4 		$160K Buy
+23,216
New +$172K 0.02% 426

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Shay Capital's IMA Position: Q2 2026 in Review

Shay Capital reduced its ImageneBio Inc (IMA) stake by 5.5% in Q2 2026, selling an estimated $5.93K and leaving 18,080 shares worth $107K. The position accounts for 0.01% of the portfolio, ranked #442.

Shay Capital first reported a position in IMA in Q4 2025 and has held it in 3 quarters since. The position peaked at $160K in Q4 2025. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Shay Capital held 18,080 shares of ImageneBio Inc worth $107K as of Q2 2026.
  • Shay Capital sold 1,050 ImageneBio Inc shares in Q2 2026, an estimated $5.93K.
  • ImageneBio Inc made up 0.01% of Shay Capital's portfolio in Q2 2026, its #442 holding.
  • Shay Capital first reported a position in ImageneBio Inc in Q4 2025 and has held it in 3 quarters since.
  • Shay Capital's ImageneBio Inc position peaked at $160K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.